Krzysztof Góralczyk Selected Research

Krzysztof Góralczyk Research Topics

Disease

5	Inflammation (Inflammations) 06/2019 - 01/2012
4	Insulin Resistance 07/2013 - 01/2006
3	Hyperglycemia 09/2018 - 05/2015
3	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2012 - 09/2009
2	Neoplasms (Cancer) 12/2022 - 11/2017
2	Diabetic Foot 09/2018 - 07/2016
2	Thrombophilia 11/2017 - 07/2016
2	Type 2 Diabetes Mellitus (MODY) 05/2015 - 06/2014
2	ST Elevation Myocardial Infarction 01/2015 - 01/2013
2	Weight Gain 07/2013 - 01/2006
2	Ulcerative Colitis 01/2007 - 03/2006
1	Brain Neoplasms (Brain Tumor) 12/2022
1	Wounds and Injuries (Trauma) 09/2018
1	Diabetic Angiopathies (Diabetic Angiopathy) 07/2016
1	Infarction (Infarctions) 01/2015
1	Morbid Obesity 11/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2013
1	Myocardial Infarction 01/2013
1	Dyslipidemias (Dyslipidemia) 02/2012
1	Glucose Intolerance 02/2012
1	Atherosclerosis 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Idiopathic Pulmonary Fibrosis 01/2008
1	Chest Pain (Chest Pains) 10/2007
1	Lymphoid Leukemia 03/2006

Drug/Important Bio-Agent (IBA)

4	Plasminogen Activator Inhibitor 1IBA 11/2013 - 03/2006
4	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 09/2009
3	lipoprotein-associated coagulation inhibitor (TFPI)IBA 12/2022 - 07/2016
3	E-SelectinIBA 05/2015 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2013
3	AntigensIBA 07/2013 - 03/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2012 - 03/2006
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2007 - 03/2006
2	Thromboplastin (Tissue Factor)IBA 12/2022 - 11/2017
2	Thrombin FDA Link 12/2022 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 06/2019 - 01/2013
2	Protein CIBA 11/2017 - 01/2008
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2015 - 02/2012
2	ThrombomodulinIBA 05/2015 - 01/2008
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2015 - 02/2012
2	angiogeninIBA 01/2015 - 01/2013
2	MetalsIBA 01/2015 - 01/2013
2	Insulin (Novolin)FDA Link 07/2013 - 01/2006
2	C-Reactive ProteinIBA 01/2013 - 02/2012
2	Plasminogen InactivatorsIBA 02/2012 - 03/2006
2	Biomarkers (Surrogate Marker)IBA 02/2012 - 01/2012
2	LipidsIBA 02/2012 - 01/2012
1	AntithrombinsIBA 12/2022
1	CytokinesIBA 06/2019
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	PlasminogenIBA 07/2013
1	Interleukin-8 (Interleukin 8)IBA 01/2013
1	Triglycerides (Triacylglycerol)IBA 02/2012
1	Von Willebrand antigenIBA 02/2012
1	HDL CholesterolIBA 02/2012
1	SelectinsIBA 01/2012
1	antithrombin III-protease complexIBA 01/2008
1	Protein SIBA 01/2008
1	AnticoagulantsIBA 01/2008
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2007
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2007
1	Blood Glucose (Blood Sugar)IBA 01/2006

Therapy/Procedure

3	Therapeutics 07/2013 - 02/2012
2	Low-Level Light Therapy (LLLT) 09/2018 - 07/2016
2	Lasers (Laser) 09/2018 - 07/2016
2	Stents 01/2015 - 01/2013
2	Percutaneous Coronary Intervention 01/2015 - 01/2013
1	Phototherapy (Light Therapy) 07/2016